The Japan Times - US greenlights pig kidney transplant trials

EUR -
AED 4.261823
AFN 72.528622
ALL 95.935053
AMD 436.604425
ANG 2.077337
AOA 1064.150424
ARS 1621.684021
AUD 1.663207
AWG 2.091456
AZN 1.972013
BAM 1.954452
BBD 2.332621
BDT 142.111955
BGN 1.983601
BHD 0.438117
BIF 3439.697273
BMD 1.160469
BND 1.481865
BOB 8.020501
BRL 6.074711
BSD 1.158116
BTN 108.517535
BWP 15.868983
BYN 3.428635
BYR 22745.199827
BZD 2.329323
CAD 1.598094
CDF 2642.961246
CHF 0.915871
CLF 0.026976
CLP 1065.148777
CNY 7.998767
CNH 7.998895
COP 4299.910399
CRC 539.611441
CUC 1.160469
CUP 30.752439
CVE 110.190403
CZK 24.433652
DJF 206.240378
DKK 7.472013
DOP 69.380041
DZD 153.640876
EGP 61.01957
ERN 17.407041
ETB 179.036181
FJD 2.578854
FKP 0.867133
GBP 0.866
GEL 3.139098
GGP 0.867133
GHS 12.653325
GIP 0.867133
GMD 85.292098
GNF 10150.909299
GTQ 8.868996
GYD 242.379647
HKD 9.082976
HNL 30.666918
HRK 7.534805
HTG 151.853926
HUF 389.479638
IDR 19618.89532
ILS 3.626872
IMP 0.867133
INR 108.973471
IQD 1517.153299
IRR 1523725.306455
ISK 143.805664
JEP 0.867133
JMD 182.758401
JOD 0.822797
JPY 184.274992
KES 150.094719
KGS 101.48131
KHR 4647.753411
KMF 494.360206
KPW 1044.43909
KRW 1738.07561
KWD 0.355684
KYD 0.965134
KZT 559.094274
LAK 24934.797199
LBP 103717.344221
LKR 364.038845
LRD 212.526123
LSL 19.743978
LTL 3.426564
LVL 0.701956
LYD 7.384001
MAD 10.796712
MDL 20.256025
MGA 4835.55972
MKD 61.640187
MMK 2437.180177
MNT 4142.258418
MOP 9.333261
MRU 46.18974
MUR 54.019143
MVR 17.940903
MWK 2008.171278
MXN 20.59192
MYR 4.588517
MZN 74.165781
NAD 19.743978
NGN 1596.35309
NIO 42.620229
NOK 11.270577
NPR 173.62098
NZD 1.991586
OMR 0.446197
PAB 1.158106
PEN 4.005936
PGK 5.001506
PHP 69.543442
PKR 323.562653
PLN 4.270452
PYG 7556.884098
QAR 4.223341
RON 5.09539
RSD 117.49978
RUB 93.417
RWF 1694.279997
SAR 4.356053
SBD 9.332465
SCR 16.6447
SDG 697.44196
SEK 10.82353
SGD 1.483712
SHP 0.870653
SLE 28.554417
SLL 24334.475204
SOS 661.82344
SRD 43.331609
STD 24019.373166
STN 24.482898
SVC 10.134008
SYP 128.752055
SZL 19.742295
THB 37.923957
TJS 11.112577
TMT 4.073248
TND 3.397
TOP 2.794131
TRY 51.462205
TTD 7.868571
TWD 37.054951
TZS 2979.57356
UAH 50.862514
UGX 4336.951829
USD 1.160469
UYU 47.198048
UZS 14129.252068
VES 532.514054
VND 30571.405319
VUV 138.685458
WST 3.177599
XAF 655.490648
XAG 0.015768
XAU 0.000253
XCD 3.136226
XCG 2.08726
XDR 0.81522
XOF 655.513227
XPF 119.331742
YER 276.891239
ZAR 19.661367
ZMK 10445.613833
ZMW 21.918162
ZWL 373.670667
  • CMSD

    -0.1100

    22.63

    -0.49%

  • CMSC

    -0.0100

    22.87

    -0.04%

  • NGG

    0.2700

    82.33

    +0.33%

  • BCE

    0.0700

    25.83

    +0.27%

  • AZN

    1.7100

    185.78

    +0.92%

  • BTI

    -0.1600

    57.76

    -0.28%

  • GSK

    0.9600

    52.95

    +1.81%

  • BCC

    1.6900

    73.57

    +2.3%

  • RBGPF

    -13.5000

    69

    -19.57%

  • BP

    1.2200

    44.79

    +2.72%

  • RIO

    0.9300

    86.77

    +1.07%

  • JRI

    0.1800

    11.86

    +1.52%

  • RYCEF

    -0.2800

    15.69

    -1.78%

  • RELX

    -1.3500

    32.46

    -4.16%

  • VOD

    0.1800

    14.66

    +1.23%

US greenlights pig kidney transplant trials
US greenlights pig kidney transplant trials / Photo: Andrew Caballero-Reynolds - AFP/File

US greenlights pig kidney transplant trials

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.

Text size:

United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.

Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.

United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.

The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.

The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.

Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.

"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.

Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.

Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.

Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.

United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.

Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.

She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.

T.Sato--JT